Credit card and PayPal contributions are working again. If you saw a "temporarily unavailable" message between October 10 and 14, we apologize - please try again. Thank you for supporting QuantumOnline.com.
Log in Register
    Faeth Therapeutics, Inc. (FTH)
    NGM · Common · CUSIP 81728A207
    Last Price•••.••
    Current Yield•.••%
    Yield to Call•.••%
    Yield to Worst•.••%
    Register free Already a member? Log in
    Free registration unlocks the quote, yield calculations, price chart and full fundamentals for FTH and every other security on QuantumOnline.
    Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒
    🔒
    Price chart and 15 days of daily prices
    Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

    Security Profile

    Security Type
    Common Stock
    CUSIP
    81728A207 (prev. 81728A108 )
    Market Cap
    Micro Cap
    IPO
    2/4/2021 · $19.00/share
    Prospectus
    IPO prospectus »
    Links: Home Page Investor Relations News
    Business: Sensei Biotherapeutics, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of next generation therapies with an initial focus on treatments for cancer.
    Notes: AUTO-CRE

    Company Contact

    CEO
    Anand Parikh
    CFO
    Brian Stephenson
    Headquarters
    1405 Research Boulevard, Suite 125, Rockville, MD 20850
    Phone
    240-243-8000
    Investor Relations
    Julie Seidel, Stern IR · 212-362-1200 · julie.seidel@sternir.com
    Email Form
    Contact Form »
    SEC EDGAR Filings
    View filings »
    QuantumOnline.com
    Copyright © 1997–2026 QuantumOnline.com. All rights reserved.